Why the study?
Does surgical treatment in elderly patients (≥ 75 years) have comparable outcomes to younger patients (< 75 years) with colorectal adenocarcinoma?
Does surgical treatment in elderly patients (≥ 75 years) have comparable outcomes to younger patients (< 75 years) with colorectal adenocarcinoma?
Surgical treatment for colorectal adenocarcinoma in elderly patients (≥ 75 years) yields acceptable short-term outcomes comparable to younger patients.
May support surgery in selected elderly colorectal cancer patients; leaves open randomized confirmation.
AIM: To compare the outcome of surgical treatment of colorectal adenocarcinoma in elderly and younger patients. METHODS: The outcomes of 122 patients with colorectal adenocarcinoma who underwent surgical treatment between January 2004 and June 2009 were analyzed. The clinicopathological and blood biochemistry data of the younger group (< 75 years) and the elderly group (≥ 75 years) were compared. RESULTS: There were no significant differences between the two groups in operation time, intraoperative blood loss, hospital stay, time to resumption of oral intake, or morbidity. The elderly group had a significantly higher rate of hypertension and cardiovascular disease. The perioperative serum total protein and albumin levels were significantly lower in the elderly than in the younger group. The serum carcinoembryonic antigen level was lower in the elderly than in the younger group, and there was a significant decreasing trend after the operation in the elderly group. CONCLUSION: The short-term outcomes of surgical treatment in elderly patients with colorectal adenocarcinoma were acceptable. Surgical treatment in elderly patients was considered a selectively effective approach.
No takes yet. Share an insight, caveat, or question.
Longxue Jin (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: